In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1852 News Items found
MSK breast cancer specialist Pedram Razavi, MD, PhD.
Article
Latest Research Into Overcoming Resistance to Breast Cancer Targeted Therapies

Learn how MSK's researchers are making important strides in overcoming breast cancer resistance.
Andy Minn
The Future of Immunotherapy Research at MSK: A Conversation With Dr. Andy Minn, Chair of MSK’s New Immuno-Oncology Program

Dr. Andy Minn, the inaugural chair of MSK's Immuno-Oncology Program, discusses his vision for the program and what it means for patients.
Sara Teichholtz stands in front of the water holding her son.
How Routine Prenatal Tests Can Detect Cancer and What It Means for Pregnant Women 

Learn how noninvasive prenatal tests designed to screen for genetic abnormalities in the fetus may detect the presence of cancer in pregnant women.
MSK computational oncologist Benjamin Greenbaum.
In the Lab
New Research Helps Model How the Immune System Shapes Cancer Development

Read about MSK research that sheds light on how the innate immune system interacts with developing cancer cells.
The co-leaders of the MSK Lobular Breast Cancer program are seen together.
What Is Invasive Lobular Carcinoma? MSK Doctors Explain

Learn about how MSK’s new Lobular Breast Cancer Program is working to improve outcomes for people with invasive lobular breast cancer and other types of LBC.
Dr. Nancy Lee, Dr. Alan Ho, and Dr. Richard Wong review scans on a computer
ASTRO 2025 Highlights From MSK

Learn about some of the exciting research that MSK doctors and scientists presented at the 2025 Annual Meeting of the American Society for Radiation Oncology.
Chrysothemis Brown
Immunologist Chrysothemis Brown Named a 2025 Howard Hughes Medical Institute Freeman Hrabowski Scholar

Dr. Brown, whose research has been shedding light on the development of the early life immune system and its relationship to autoimmunity, allergy, inflammation and cancer, was among 30 early career scientists nationwide selected for the 2025 class of scholars.
MSK radiation oncologist Dr. Nancy Lee.
Clinical Update
Pembrolizumab for Locally Advanced Head and Neck Squamous Cell Carcinoma Approved by the FDA for Use Before and After Surgery

Read about an FDA approval for immunotherapy to treat head and neck squamous cell carcinoma.
Lab member using a next-generation sequencing machine
To Study Treatment Resistance in High-Grade Serous Ovarian Cancer, MSK Researchers Develop New Approach

An MSK research team aims to find new ways to stop the most common and deadly form of ovarian cancer — high-grade serous ovarian cancer — from recurring with the help of a method they developed for tracking the evolution of treatment resistant cells in ovarian cancer using blood tests.
Harini Veeraraghavan stands in front of a radiology display
How MSK Doctors Are Using AI To Improve Radiation Treatment

MSK researchers are leading the development of new artificial intelligence (AI) models to improve the targeting of radiation therapy — teaching computers to better isolate tumors and spare more of the surrounding healthy tissue.